國家衛生研究院 NHRI:Item 3990099045/13582

NHRI > National Institute of Environmental Health Sciences > Shau-Ku Huang > Periodical Articles > Item 3990099045/13582

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13582

Title:	Hyperbaric oxygen therapy alleviates the autoimmune encephalomyelitis via the reduction of IL-17a and GM-Csf production of autoreactive T cells as well as boosting the immunosuppressive IL-10 in the central nervous system tissue Lesions
Authors:	Chiou, CHY;Huang, SH;Hung, CH;Tsai, SM;Kuo, HR;Huang, YR;Wang, JW;Chen, SC;Kuo, CH;Wu, DC;Huang, SK;Hsu, SH;Lin, MH
Contributors:	National Institute of Environmental Health Sciences
Abstract:	Multiple sclerosis (MS) is a chronic autoimmune disease mainly caused by autoreactive T cells, followed by neuronal demyelination and disabling paralysis. Hyperbaric oxygen therapy (HBOT) is usually an adjunct to therapy for the treatment of neurological disorders. However, it remains still controversial whether HBOT is an effective option for the treatment of MS. Experimental autoimmune encephalomyelitis (EAE) is a well-studied mouse model investigated for the MS pathogenesis and the efficacy of the therapeutic intervention. Both encephalitogenic Th1 and Th17 are pivotal T cell subsets immunopathogenically producing several disease-initiating/modifying cytokines in the central nervous system (CNS) lesions to further exacerbate/ameliorate the progression of EAE or MS. However, it remains unclear whether HBOT modulates the context of T helper cell subsets in CNS lesions. We employed EAE in the presence of HBOT to assess whether disease amelioration is attributed to alterations of CNS-infiltrating T cell subsets. Our results demonstrated that semi-therapeutic HBOT significantly alleviated the progression of EAE, at least, via the suppression of Th17 response, the downregulation of CD4 T helper cells expressing GM-CSF or TNF-α, and the boosting of immunomodulatory IL-4 or IL-10-expressed CD4 T cells in the CNS lesions. Conclusively, HBOT attenuated EAE through the modulation of T cell responses in an earlier stage
Date:	2021-08-02
Relation:	Biomedicines. 2021 Aug 2;9(8):Article number 943.
Link to:	https://doi.org/10.3390/biomedicines9080943
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2227-9059&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000688787900001
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85112616373
Appears in Collections:	[Shau-Ku Huang] Periodical Articles

Files in This Item:

File	Description	Size	Format
NEM2021080501.pdf		2927Kb	Adobe PDF	273	View/Open

Loading...